Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment

Osteoporosis International

Volumn 22, Issue 3, 2011, Pages 817-827

  Leslie, W D ^a,i   Lix, L M ^b   Langsetmo, L ^c   Berger, C ^c   Goltzman, D ^c   Hanley, D A ^d   Adachi, J D ^e   Johansson, H ^f   Oden, A ^f   McCloskey, E ^g   Kanis, J A ^h  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f Northern General Hospital ^*

^g NORTHERN GENERAL HOSPITAL   (United Kingdom)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Bone mineral density; Canada; Clinical risk factors; Fracture; FRAX ; Osteoporosis

Indexed keywords

ARTICLE; BONE DENSITY; CALIBRATION; CANADA; GROUPS BY AGE; HIP FRACTURE; HUMAN; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

EID: 79951675896     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1464-2     Document Type: Article

References (53)

1. A Tenenhouse L Joseph N Kreiger, et al. 2000 Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos) Osteoporos Int 11 897 904 1:STN:280:DC%2BD3M7isV2msQ%3D%3D 10.1007/s001980070050 11199195 (Pubitemid 32049481)
2. WD Leslie S O'Donnell C Lagace, et al. 2009 Population-based Canadian hip fracture rates with international comparisons Osteoporos Int 21 1317 1322 10.1007/s00198-009-1080-1 19802507
3. ME Wiktorowicz R Goeree A Papaioannou, et al. 2001 Economic implications of hip fracture: health service use, institutional care and cost in Canada Osteoporos Int 12 271 278 1:STN:280:DC%2BD3MzmtVCrtw%3D%3D 10.1007/s001980170116 11420776 (Pubitemid 34912733)
4. A Papaioannou JD Adachi W Parkinson, et al. 2001 Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions Osteoporos Int 12 870 874 1:STN:280:DC%2BD3MnntVCnuw%3D%3D 10.1007/s001980170039 11716191 (Pubitemid 33086275)
5. JR Center TV Nguyen D Schneider, et al. 1999 Mortality after all major types of osteoporotic fracture in men and women: an observational study Lancet 353 878 882 1:STN:280:DyaK1M7ptFOlug%3D%3D 10.1016/S0140-6736(98)09075-8 10093980 (Pubitemid 29126875)
6. O Johnell JA Kanis A Oden, et al. 2004 Mortality after osteoporotic fractures Osteoporos Int 15 38 42 1:STN:280:DC%2BD2c%2FitlOhsw%3D%3D 10.1007/s00198-003-1490-4 14593451 (Pubitemid 38252438)
7. G Ioannidis A Papaioannou WM Hopman, et al. 2009 Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study CMAJ 181 265 271 19654194
8. JA Kanis A Oden O Johnell, et al. 2003 The components of excess mortality after hip fracture Bone 32 468 473 1:STN:280:DC%2BD3s3jtVGhtg%3D%3D 10.1016/S8756-3282(03)00061-9 12753862 (Pubitemid 39665705)
9. JA Kanis A Oden O Johnell, et al. 2004 Excess mortality after hospitalisation for vertebral fracture Osteoporos Int 15 108 112 10.1007/s00198-003-1516-y 14598026 (Pubitemid 38252423)
10. JD Adachi G Ioannidis C Berger, et al. 2001 The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada Osteoporos Int 12 903 908 1:STN:280:DC%2BD38%2FnvVWnuw%3D%3D 10.1007/s001980170017 11804016 (Pubitemid 34001002)
11. I Hallberg AM Rosenqvist L Kartous, et al. 2004 Health-related quality of life after osteoporotic fractures Osteoporos Int 15 834 841 1:STN:280:DC%2BD2cvlvFGnsQ%3D%3D 10.1007/s00198-004-1622-5 15045468 (Pubitemid 39361955)
12. JA Kanis LJ Melton III C Christiansen, et al. 1994 The diagnosis of osteoporosis J Bone Miner Res 9 1137 1141 1:STN:280:DyaK2M%2FmslSisA%3D%3D 10.1002/jbmr.5650090802 7976495 (Pubitemid 24985932)
13. AC Looker HW Wahner WL Dunn, et al. 1998 Updated data on proximal femur bone mineral levels of US adults Osteoporos Int 8 468 489 1:STN:280: DyaK1M%2FmslensA%3D%3D 10.1007/s001980050093 9850356 (Pubitemid 28486716)
14. JA Kanis EV McCloskey H Johansson, et al. 2008 A reference standard for the description of osteoporosis Bone 42 467 475 1:CAS:528:DC%2BD1cXitVOmtbk%3D 10.1016/j.bone.2007.11.001 18180210
15. A Cranney SA Jamal JF Tsang, et al. 2007 Low bone mineral density and fracture burden in postmenopausal women CMAJ 177 575 580 17846439 (Pubitemid 47437054)
16. JA Kanis A Oden O Johnell, et al. 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1033 1046 1:STN:280: DC%2BD2sznvV2hug%3D%3D 10.1007/s00198-007-0343-y 17323110 (Pubitemid 47020000)
17. JA Kanis A Oden H Johansson, et al. 2009 FRAX and its applications to clinical practice Bone 44 734 743 10.1016/j.bone.2009.01.373 19195497
18. JA Kanis O Johnell C De Laet, et al. 2002 International variations in hip fracture probabilities: implications for risk assessment J Bone Miner Res 17 1237 1244 10.1359/jbmr.2002.17.7.1237 12096837 (Pubitemid 34680500)
19. JA Kanis O Johnell A Oden, et al. 2008 FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385 397 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D 10.1007/s00198-007-0543-5 18292978
20. B Dawson-Hughes AN Tosteson LJ Melton III, et al. 2008 Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA Osteoporos Int 19 449 458 1:STN:280:DC%2BD1c7nvF2nsQ%3D%3D 10.1007/s00198-008-0559-5 18292975
21. S Fujiwara T Nakamura H Orimo, et al. 2008 Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX) Osteoporos Int 19 429 435 1:STN:280:DC%2BD1c7nvF2ntw%3D%3D 10.1007/s00198-007-0544-4 18292977
22. K Lippuner H Johansson JA Kanis, et al. 2009 Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women Osteoporos Int 20 1131 1140 1:STN:280:DC%2BD1MzptVOluw%3D%3D 10.1007/s00198-008-0779-8 18974918
23. K Siminoski WD Leslie H Frame, et al. 2005 Recommendations for bone mineral density reporting in Canada Can Assoc Radiol J 56 178 188 16144280 (Pubitemid 41133860)
24. B Dawson-Hughes 2008 A revised clinician's guide to the prevention and treatment of osteoporosis J Clin Endocrinol Metab 93 2463 2465 1:CAS:528:DC%2BD1cXoslyktLs%3D 10.1210/jc.2008-0926 18544615 (Pubitemid 352008504)
25. B Dawson-Hughes AC Looker AN Tosteson, et al. 2010 The potential impact of new National Osteoporosis Foundation guidance on treatment patterns Osteoporos Int 21 41 52 1:STN:280:DC%2BD1Mjptlaqsg%3D%3D 10.1007/s00198-009- 1034-7 19705046
26. JA Kanis H Johansson A Oden, et al. 2010 The effects of a FRAX® revision for the USA Osteoporos Int 21 35 40 1:STN:280:DC%2BD1Mjptlaqsw%3D%3D 10.1007/s00198-009-1033-8 19705047
27. B Ettinger DM Black B Dawson-Hughes, et al. 2010 Updated fracture incidence rates for the US version of FRAX Osteoporos Int 21 25 33 1:STN:280:DC%2BD1MjptlaqsA%3D%3D 10.1007/s00198-009-1032-9 19705048
28. Richards J, Brown A, Homan C (2001) The data quality study of the Canadian discharge abstract database: a methodological perspective. Proceedings of Statistics Canada Symposium: Achieving data quality in a statistical agency. Statistics Canada, Ottawa Last accessed: June 6, 2009. URL: http://secure.cihi. ca/cihiweb/en/downloads/quality-dadconfpaper-e.pdf
29. Canadian Institute for Health Information (2008) Quality Assurance Processes Applied to the Discharge Abstract and Hospital Morbidity Databases. CIHI, Ottawa Last accessed: Aug. 3, 2009. URL: http://secure.cihi.ca/cihiweb/en/ downloads/quality-assurance-proc-apr08-e.pdf
30. N Kreiger A Tenenhouse L Joseph, et al. 1999 Research notes: the Canadian Multicentre Osteoporosis Study (CaMos)-background, rationale, methods Can J Aging 18 376 387 10.1017/S0714980800009934
31. HK Genant 1995 Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results J Bone Miner Res 10 997 998 1:STN:280:DyaK28%2Fht1amtQ%3D%3D 10.1002/jbmr.5650100623 7572326
32. C Berger L Langsetmo L Joseph, et al. 2008 Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents Can Med Assoc J 178 1660 1668 10.1503/cmaj.071416 (Pubitemid 351897981)
33. WD Leslie C Metge 2003 Establishing a regional bone density program: lessons from the Manitoba experience J Clin Densitom 6 275 282 10.1385/JCD:6:3:275 14514998 (Pubitemid 37194011)
34. WD Leslie L MacWilliam L Lix, et al. 2005 A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service Osteoporos Int 16 773 782 10.1007/s00198-004-1756-5 15580480 (Pubitemid 40941013)
35. WD Leslie PA Caetano LR MacWilliam, et al. 2005 Construction and validation of a population-based bone densitometry database J Clin Densitom 8 25 30 10.1385/JCD:8:1:025 15722584 (Pubitemid 40392924)
36. WD Leslie 2006 The importance of spectrum bias on bone density monitoring in clinical practice Bone 39 361 368 10.1016/j.bone.2006.02.002 16537116 (Pubitemid 43851370)
37. NP Roos E Shapiro 1999 Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system Med Care 37 JS10 JS14 1:STN:280:DyaK1MzhsVOjtQ%3D%3D 10.1097/00005650-199906001-00005 10409002
38. Giangregorio L, Leslie WD (2010) Time since prior fracture is a risk modifier for ten year osteoporotic fractures. J Bone Miner Res (in press)
39. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2010) Independent clinical validation of a Canadian FRAX® Tool: fracture prediction and model calibration. J Bone Miner Res
40. Kanis JA (2007) WHO Scientific group on the assessment of osteoporosis at primary health care level. Brussels, Belgium
41. H Johansson JA Kanis A Oden, et al. 2009 BMD, clinical risk factors and their combination for hip fracture prevention Osteoporos Int 20 1675 1682 1:STN:280:DC%2BD1MngtFaquw%3D%3D 10.1007/s00198-009-0845-x 19291344
42. JA Kanis EV McCloskey H Johansson, et al. 2008 Case finding for the management of osteoporosis with FRAX((R))-assessment and intervention thresholds for the UK Osteoporos Int 19 1395 1408 1:STN:280:DC%2BD1crnvFelug%3D%3D 10.1007/s00198-008-0712-1 18751937
43. WD Leslie K Siminoski JP Brown 2007 Comparative effects of densitometric and absolute fracture risk classification systems on projected intervention rates in postmenopausal women J Clin Densitom 10 124 131 10.1016/j.jocd.2007.01. 003 17485029 (Pubitemid 46678863)
44. JB Richards WD Leslie L Joseph, et al. 2007 Changes to osteoporosis prevalence according to method of risk assessment J Bone Miner Res 22 228 234 10.1359/jbmr.061109 17129177 (Pubitemid 46167793)
45. KW Lyles CS Colon-Emeric JS Magaziner, et al. 2007 Zoledronic acid and clinical fractures and mortality after hip fracture N Engl J Med 357 1799 1809 1:CAS:528:DC%2BD2sXht1Kit7nN 10.1056/NEJMoa074941 17878149 (Pubitemid 350044800)
46. JA Kanis IP Barton O Johnell 2005 Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture Osteoporos Int 16 475 482 1:CAS:528:DC%2BD2MXlsFSku7Y%3D 10.1007/s00198-004-1698-y 15875093
47. JA Kanis H Johansson A Oden, et al. 2009 Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX Bone 44 1049 1054 1:CAS:528:DC%2BD1MXlslWisrw%3D 10.1016/j.bone.2009.02.014 19254788
48. EV McCloskey H Johansson A Oden, et al. 2009 Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study Osteoporos Int 20 811 817 1:CAS:528:DC%2BD1MXjvFaqt78%3D 10.1007/s00198-008-0786-9 19002369
49. AN Tosteson LJ Melton III B Dawson-Hughes, et al. 2008 Cost-effective osteoporosis treatment thresholds: the United States perspective Osteoporos Int 19 437 447 1:STN:280:DC%2BD1c7nvF2ntg%3D%3D 10.1007/s00198-007-0550-6 18292976
50. AN Tosteson RT Burge DA Marshall, et al. 2008 Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations Am J Manag Care 14 605 615 18778176
51. MG Donaldson PM Cawthon LY Lui, et al. 2009 Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines J Bone Miner Res 24 675 680 10.1359/jbmr.081203 19049330
52. Fraser LA, Langsetmo L, Berger C et al (2010) Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (in press)
53. Leslie WD, Lix LM, Johansson H et al (2010) Independent clinical validation of a Canadian FRAX((R)) tool: Fracture prediction and model calibration. J Bone Miner Res [epub ahead of print]